Transaction DateRecipientSharesTypePriceValue
22nd December 2020Management Inc. Opaleye496,277Open or private purchase$8.06$3,999,992.62
22nd December 2020Management Inc. Opaleye657Open or private purchase$5.19$3,412.98
22nd December 2020Management Inc. Opaleye15,900Open or private purchase$5.19$82,597.32
21st December 2020Management Inc. Opaleye51,400Open or private purchase$5.24$269,305.16
21st December 2020Management Inc. Opaleye2,059Open or private purchase$5.24$10,787.92
18th December 2020Management Inc. Opaleye35,000Open or private purchase$5.31$185,941.00
18th December 2020Management Inc. Opaleye1,400Open or private purchase$5.31$7,437.64
2nd November 2020Charles J Casamento3,000Open or private sale$30.29$90,863.70
21st October 2020Management Inc. Opaleye3,000Open or private purchase$4.40$13,190.70
21st October 2020Management Inc. Opaleye5,656Open or private purchase$4.40$24,868.87
Eton Pharmaceuticals
Eton Pharmaceuticals logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.

Eton Pharmaceuticals, Inc. engages in the development and commercialization of prescription drug products. Its portfolio consists of injectable, oral liquid, ophthalmic products pipelines.

Ticker: ETON
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1710340
Employees: 17
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags